Protect Your Rights

Contact Our Lawyers
for a free consultation
toll free (866) 761-1385
or tell us about yourself below
:
Tendonitis
Tendon Rupture

Levaquin is One Fluoroquinolone Antibiotic Putting You at Risk: Do You Know the Others?

 

Levaquin Lawsuit Information AddThis Social Bookmark Button

Levaquin and its manufacturer, Ortho-McNeil-Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), have been in the news quite often recently.

Levaquin is a broad spectrum antibiotic used to treat bacterial infections of the skin, lungs, sinuses, and urinary tract. It is a fluorinated derivative of a quinolone compound that puts patients who take it at risk for tendonitis or rupture. The increased risk of rupture is found in all ages and is significantly higher in those over 60, post-transplant patients, and people taking corticosteroids.

While Levaquin remains in the limelight, in actuality there are several fluoroquinolone antibiotics on the market. Consumers may not be aware of the names of these drugs that carry the same significant risk factors as does Levaquin.

Do You Have A Levaquin Antibiotic Case? »

Johnson & Johnson (J&J) not only produce Levaquin; they also manufacture Floxin, a fluoroquinolone derivative that must contain the black box warning. Merck & Co. produce Noroxin (generic name norfloxacin), a broad spectrum antibiotic, also includes the black box warning that covers the increased risk of tendon rupture among patients.

Cipro, Cipro XR (generic name ciprofloxacin hydrochloride), from Bayer Healthcare Pharmaceuticals and Schering-Plough, is also subject to the black box warning issued by the FDA. Avelox (generic name moxifloxacin hydrochloride), another product from Bayer Healthcare Pharmaceuticals and Schering-Plough, also contains the black box warning on its prescribing and patient information. Proquin and Proquin XR (ciprofloxacin hydrochloride) from Depomed, Inc. is yet another fluoroquinolone drug. Factive (gemifloxacin mesylate) from Oscient Pharmaceuticals is also required to carry the black box warning.

The pharmaceutical companies were aware of the significant increase in risk of tendonitis and tendon rupture for many years, yet they did very little to inform the prescribing physicians, pharmacists, and patients of these risks. Tendon rupture is extremely painful and debilitating. The condition may require surgery and several months of recovery. The black box warnings were not in effect until July of 2008. Most of these drugs were approved for use in 1996. That is 12 years of doctors prescribing these drugs to their patients both parties unaware of the extreme risks associated with the medicatons.

Contact Our Levaquin Lawyers Today »

If you, or someone you know, has taken Levaquin, Floxin, Noroxin, Cipro, Avelox, Proquin, or Factive and has suffered a tendon injury or rupture, please seek legal advice in regards to your right to compensation.

Philadelphia Lawyers - Pennsylvania Lawsuits at Monheit Law

Law Offices of Michael Monheit 1368 Barrowdale Road  Rydal, PA  19046
Call Us Toll Free: 866-761-1385  P: 215-840-6573  E: Michael@Monheit.com